The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

Morabaha Marina Financing Co. (MRNA) said it will not be able to release its preliminary financial results for the ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in April, moving ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

As other fact checkers have reported in 2021 and 2023, the US Supreme Court hasn’t issued any rulings that Covid vaccines are ...

A study from Karolinska Institutet reveals how cells adapt to nutrient scarcity by altering their genetic instructions. This ...

HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine.

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.